220 related articles for article (PubMed ID: 31287093)
1. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a
Zhao W; Esquinas PL; Frezza A; Hou X; Beauregard JM; Celler A
Phys Med Biol; 2019 Aug; 64(17):175006. PubMed ID: 31287093
[No Abstract] [Full Text] [Related]
2. Personalized kidney dosimetry in
Hou X; Zhao W; Beauregard JM; Celler A
Phys Med Biol; 2019 Aug; 64(17):175004. PubMed ID: 31456584
[TBL] [Abstract][Full Text] [Related]
3. A dosimetry procedure for organs-at-risk in
Marin G; Vanderlinden B; Karfis I; Guiot T; Wimana Z; Reynaert N; Vandenberghe S; Flamen P
Phys Med; 2018 Dec; 56():41-49. PubMed ID: 30527088
[TBL] [Abstract][Full Text] [Related]
4. Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [
Mansouri Z; Salimi Y; Akhavanallaf A; Shiri I; Teixeira EPA; Hou X; Beauregard JM; Rahmim A; Zaidi H
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1516-1529. PubMed ID: 38267686
[TBL] [Abstract][Full Text] [Related]
5. Effect of calculation method on kidney dosimetry in
Heikkonen J; Mäenpää H; Hippeläinen E; Reijonen V; Tenhunen M
Acta Oncol; 2016; 55(9-10):1069-1076. PubMed ID: 27219529
[TBL] [Abstract][Full Text] [Related]
6. 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.
Garkavij M; Nickel M; Sjögreen-Gleisner K; Ljungberg M; Ohlsson T; Wingårdh K; Strand SE; Tennvall J
Cancer; 2010 Feb; 116(4 Suppl):1084-92. PubMed ID: 20127957
[TBL] [Abstract][Full Text] [Related]
7. A radiomic- and dosiomic-based machine learning regression model for pretreatment planning in
Plachouris D; Eleftheriadis V; Nanos T; Papathanasiou N; Sarrut D; Papadimitroulas P; Savvidis G; Vergnaud L; Salvadori J; Imperiale A; Visvikis D; Hazle JD; Kagadis GC
Med Phys; 2023 Nov; 50(11):7222-7235. PubMed ID: 37722718
[TBL] [Abstract][Full Text] [Related]
8. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog
Zhang J; Wang H; Jacobson O; Cheng Y; Niu G; Li F; Bai C; Zhu Z; Chen X
J Nucl Med; 2018 Nov; 59(11):1699-1705. PubMed ID: 29653971
[TBL] [Abstract][Full Text] [Related]
9. The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOC.
Schuchardt C; Kulkarni HR; Prasad V; Zachert C; Müller D; Baum RP
Recent Results Cancer Res; 2013; 194():519-36. PubMed ID: 22918780
[TBL] [Abstract][Full Text] [Related]
10. Particle filter de-noising of voxel-specific time-activity-curves in personalized
Götz TI; Lang EW; Schmidkonz C; Maier A; Kuwert T; Ritt P
Z Med Phys; 2020 May; 30(2):116-134. PubMed ID: 31859029
[TBL] [Abstract][Full Text] [Related]
11. Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.
Ilan E; Sandström M; Wassberg C; Sundin A; Garske-Román U; Eriksson B; Granberg D; Lubberink M
J Nucl Med; 2015 Feb; 56(2):177-82. PubMed ID: 25593115
[TBL] [Abstract][Full Text] [Related]
12. 4D SPECT/CT acquisition for 3D dose calculation and dose planning in (177)Lu-peptide receptor radionuclide therapy: applications for clinical routine.
Kairemo K; Kangasmäki A
Recent Results Cancer Res; 2013; 194():537-50. PubMed ID: 22918781
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent
Goetz TI; Lang EW; Prante O; Maier A; Cordes M; Kuwert T; Ritt P; Schmidkonz C
Ann Nucl Med; 2020 Apr; 34(4):244-253. PubMed ID: 32114682
[TBL] [Abstract][Full Text] [Related]
14. The Influence of Early Measurements Onto the Estimated Kidney Dose in [(177)Lu][DOTA(0),Tyr(3)]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors.
Delker A; Ilhan H; Zach C; Brosch J; Gildehaus FJ; Lehner S; Bartenstein P; Böning G
Mol Imaging Biol; 2015 Oct; 17(5):726-34. PubMed ID: 25790773
[TBL] [Abstract][Full Text] [Related]
15. Kidney dosimetry during
Sandström M; Garske-Román U; Johansson S; Granberg D; Sundin A; Freedman N
Acta Oncol; 2018 Apr; 57(4):516-521. PubMed ID: 28920501
[TBL] [Abstract][Full Text] [Related]
16. Peptide receptor radionuclide therapy with (177)Lu labeled somatostatin analogs DOTATATE and DOTATOC: contrasting renal dosimetry in the same patient.
Kulkarni HR; Schuchardt C; Baum RP
Recent Results Cancer Res; 2013; 194():551-9. PubMed ID: 22918782
[TBL] [Abstract][Full Text] [Related]
17. SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [
Blakkisrud J; Peterson AB; Wildermann SJ; Kingkiner G; Wong KK; Wang C; Frey KA; Stokke C; Dewaraja YK
J Nucl Med; 2024 May; 65(5):753-760. PubMed ID: 38548350
[TBL] [Abstract][Full Text] [Related]
18. A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After
Dewaraja YK; Mirando DM; Peterson AB; Niedbala J; Millet JD; Mikell JK; Frey KA; Wong KK; Wilderman SJ; Nelson AS
J Nucl Med; 2022 Nov; 63(11):1665-1672. PubMed ID: 35422445
[TBL] [Abstract][Full Text] [Related]
19. Effect of image registration on 3D absorbed dose calculations in
Grassi E; Fioroni F; Berenato S; Patterson N; Ferri V; Braglia L; Filice A; Versari A; Iori M; Spezi E
Phys Med; 2018 Jan; 45():177-185. PubMed ID: 29472084
[TBL] [Abstract][Full Text] [Related]
20. Bone Marrow Absorbed Doses and Correlations with Hematologic Response During
Hagmarker L; Svensson J; Rydén T; van Essen M; Sundlöv A; Gleisner KS; Gjertsson P; Bernhardt P
J Nucl Med; 2019 Oct; 60(10):1406-1413. PubMed ID: 30902877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]